Activity and safety of atezolizumab plus carboplatin and paclitaxel in patients with advanced or recurrent thymic carcinoma (MARBLE): a multicentre, single-arm, phase 2 trial

Takehito Shukuya(Juntendo University), Tetsuhiko Asao(Juntendo University), Yasushi Goto, Tomoyasu Mimori(Juntendo University), Koichi Takayama(Kyoto Prefectural University of Medicine), Kyoichi Kaira(Saitama Medical University), Hiroshi Tanaka(Niigata Cancer Center Hospital), Ryo Ko(Shizuoka Cancer Center), Yoshihiro Amano(Shimane University), Motoko Tachihara(Kobe University), Takuji Suzuki(Chiba University), Junko Tanizaki(Kindai University), Shunichi Sugawara(Sendai Kousei Hospital), Yoshitaka Zenke(National Cancer Center Hospital East), Yukina Shirai(Juntendo University), Takuo Hayashi(Juntendo University), Keita Mori(Shizuoka Cancer Center), Kazuhisa Takahashi(Juntendo University)
The Lancet Oncology
March 1, 2025
Cited by 17

Abstract


Related Papers

No related papers found

Powered by citation graph analysis